In the individual financial statements for the third quarter of the fiscal year ending March 2026, an equity method investment loss of 13,361 million yen was recorded. There is no impact on consolidated earnings.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4005","jir_company_name":"Sumitomo Chemical Company, Limited","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-02-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4005-20260203-04.pdf","jir_short_summary":"In the individual financial statements for the third quarter of the fiscal year ending March 2026, an equity method investment loss of 13,361 million yen was recorded. There is no impact on consolidated earnings.","jir_summary":"### Regarding the Recognition of Special Loss in Individual Financial Statements\nIn the third quarter of the fiscal year ending March 2026 (October 1, 2025 to December 31, 2025), Sumitomo Chemical Company, Limited recorded an equity method investment loss of 13,361 million yen in its individual financial statements due to a significant decline in the fair value of Class A common shares of Rabigh Refining and Petrochemical Company, an equity method affiliate. The valuation loss is a result of an impairment process, and the quarterly securities valuation adopts a marking-to-market approach.\n\n### Consolidated Earnings and Future Outlook\nThe equity method investment loss recognized this time is recorded only in individual financial statements and is eliminated in the consolidated financial statements; therefore, there is no impact on consolidated earnings. However, the amount of valuation loss recognized may fluctuate depending on the stock market price situation in the fourth quarter.","jir_financial_highlights":"Equity Method Investment Loss: 13,361 million yen (Unknown)\nImpact on Consolidated Earnings: None (Unknown)","jir_category":"","jir_hashtags":"#SumitomoChemicalCompanyLimited, #financial_summary, #JapaneseStocks","jir_key_figures":"Equity Method Investment Loss: 13,361 million yen (Individual Financial Statements for Q3 Fiscal Year Ending March 2026)\nImpact on Consolidated Earnings: None (due to elimination adjustments)\nAccounting Period: October 1, 2025 to December 31, 2025 (Q3)","jir_meta_title":"Sumitomo Chemical Records Equity Method Investment Loss of 13,361 Million Yen in Q3 Fiscal Year Ending March 2026","jir_meta_description":"Sumitomo Chemical Company, Limited recorded an equity method investment loss of 13,361 million yen in its individual financial statements for the third quarter of the fiscal year ending March 2026. There is no impact on consolidated earnings.","jir_og_title":"Sumitomo Chemical Announces Equity Method Investment Loss in Q3 Fiscal Year 2026","jir_og_description":"Sumitomo Chemical Company, Limited recorded an equity method investment loss of 13,361 million yen in the third quarter of the fiscal year ending March 2026. No impact on consolidated earnings.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7702,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-23405","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n